-

Comments

Post a Comment

Popular posts from this blog

-
Image
Sleep apnea: Daytime sleepiness might help predict cardiovascular risk Published Saturday 23 February 2019 By Chiara Townley Fact checked  by Jasmin Collier A recent study categorizing people with obstructive sleep apnea based on their differing symptoms found a strong link between excessive daytime sleepiness and cardiovascular disease. OSA increases hypertension risk. Obstructive sleep apnea  (OSA) causes sporadic airflow blockages during sleep. All of the different types of sleep apnea, OSA is the most common. Symptoms include snoring, daytime sleepiness, difficulty concentrating, and  high blood pressure . OSA occurs when the throat muscles relax too much to keep the airway open. According to the National Sleep Foundation, more than  18 million  adults in the United States have sleep apnea. If a person does not seek treatment, it can lead to several complications — one of which is cardiovascular disease. Sleep apnea an...
Read more
-
Image
What to know about whooping cough in adults Last reviewed Fri 22 February 2019 By Jamie Eske Reviewed by  Vincent J. Tavella, MPH Symptoms   Diagnosis   Complications   Treatment Risk factors   Prevention   Takeaway Whooping cough, or pertussis, is a highly contagious condition. This infection is most common in infants, but people of all ages can contract it. Whooping cough  symptoms tend to be less severe in adults than in children. Unvaccinated infants have the  highest risk  of developing severe symptoms and complications from whooping cough. In this article, we discuss the symptoms and complications of whooping cough in adults and the treatment options. Symptoms in adults Whooping cough can affect adults and it is often less severe than in children. Adults tend to experience less severe symptoms of whooping cough compared with children. The reason for this is that adults have built up immunity ...
Read more

CORONA VACCINATION

-
Coronavirus vaccination in India: As coronavirus cases in the country are increasing in an indication of a second wave of the pandemic, the government is also working full force on its nation-wide COVID-19 vaccination drive. With an aim to vaccinate about 30 crore people by August, Centre has ramped up its demand for Pune-based Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin, which are the two COVID-19 vaccines that are being administered in India at the moment, according to a report in The Indian Express. The issue with the increased demand, however, is that these two companies are also expected to supply coronavirus vaccine doses to other countries as per their agreements. The report stated that at least one of the two manufacturers have said that the demand from India has exceeded the number of COVID-19 vaccine doses they had earmarked for the country, and so, their ability to fulfil requirements from other countries on time has been impacted. RELATED NEWS CII ...
Read more